Skip to main content
Equibles

Candriam S.C.A.

Position in RYTM — Rhythm Pharmaceuticals, Inc.

CIK 1537014 STRASSEN, N4
Back to RYTM Full portfolio

Position in RYTM

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$48,078,765
+$7,695,116 QoQ
Shares Held
433,025
-6.7% QoQ
Ownership
0.629%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RYTM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. RYTM ranks #12 (2.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in RYTM

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $48,078,765 433,025
2026-03-31 $40,383,649 464,340
2025-12-31 $30,817,565 287,907
2025-09-30 $22,405,944 221,863
2025-06-30 $19,743,841 312,452
2025-03-31 $15,439,112 291,469
2024-12-31 $18,607,304 332,392
2024-09-30 $20,713,801 395,377
2024-06-30 $11,143,601 271,398
2022-12-31 $945,788 32,479
2022-09-30 $936,733 38,234